Literature DB >> 12358759

Selective loss of neurofilament expression in Cu/Zn superoxide dismutase (SOD1) linked amyotrophic lateral sclerosis.

Fiona M Menzies1, Andrew J Grierson, Mark R Cookson, Paul R Heath, Janine Tomkins, Denise A Figlewicz, Paul G Ince, Pamela J Shaw.   

Abstract

Neurofilament pathology is a hallmark of sporadic and familial amyotrophic lateral sclerosis (SALS and FALS). The disease mechanisms underlying this pathology are presently unclear, but recent evidence in SALS patients suggest that reductions in neurofilament light subunit (NFL) mRNA may contribute to the death of motor neurones. Mutations in the gene encoding Cu-Zn superoxide dismutase (SOD1) represent the best-studied cause of FALS, and a number of laboratory models of SOD1-mediated disease exist. Here we have used microdissected lumbar spinal cord motor neurones from human SOD1 FALS patients as well as G93A SOD1 transgenic mice and demonstrated that reduced NFL mRNA levels are seen in both. To probe the molecular mechanisms underpinning these observations, we generated NSC34 motor neurone-like cell lines expressing wild-type and mutant SOD1. NSC34 cells expressing G37R or G93A SOD1 showed selective reductions in NFL and NFM mRNA and protein. These data suggest that NFL mRNA reductions are common to SALS and FALS patients, and that cells and mice expressing mutant SOD1 may enable us to characterize the molecular mechanism(s) responsible for the loss of neurofilament mRNA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12358759     DOI: 10.1046/j.1471-4159.2002.01045.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  22 in total

Review 1.  Epigenetics in amyotrophic lateral sclerosis: a role for histone post-translational modifications in neurodegenerative disease.

Authors:  Seth A Bennett; Royena Tanaz; Samantha N Cobos; Mariana P Torrente
Journal:  Transl Res       Date:  2018-10-12       Impact factor: 7.012

Review 2.  MicroRNAs as potential circulating biomarkers for amyotrophic lateral sclerosis.

Authors:  Frank Cloutier; Alier Marrero; Colleen O'Connell; Pier Morin
Journal:  J Mol Neurosci       Date:  2014-11-30       Impact factor: 3.444

Review 3.  Neurofilaments and Neurofilament Proteins in Health and Disease.

Authors:  Aidong Yuan; Mala V Rao; Ralph A Nixon
Journal:  Cold Spring Harb Perspect Biol       Date:  2017-04-03       Impact factor: 10.005

Review 4.  Exercise and amyotrophic lateral sclerosis.

Authors:  J P Lopes de Almeida; R Silvestre; A C Pinto; M de Carvalho
Journal:  Neurol Sci       Date:  2012-01-07       Impact factor: 3.307

Review 5.  The complex molecular biology of amyotrophic lateral sclerosis (ALS).

Authors:  Rachel L Redler; Nikolay V Dokholyan
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 6.  Mitochondria: a therapeutic target in neurodegeneration.

Authors:  Paula I Moreira; Xiongwei Zhu; Xinglong Wang; Hyoung-Gon Lee; Akihiko Nunomura; Robert B Petersen; George Perry; Mark A Smith
Journal:  Biochim Biophys Acta       Date:  2009-10-21

7.  Spinal cord mRNA profile in patients with ALS: comparison with transgenic mice expressing the human SOD-1 mutant.

Authors:  Daniel Offen; Yael Barhum; Eldad Melamed; Norbert Embacher; Christoph Schindler; Gerhard Ransmayr
Journal:  J Mol Neurosci       Date:  2008-07-24       Impact factor: 3.444

8.  3' untranslated region in a light neurofilament (NF-L) mRNA triggers aggregation of NF-L and mutant superoxide dismutase 1 proteins in neuronal cells.

Authors:  Hong Lin; Jinbin Zhai; Rafaela Cañete-Soler; William W Schlaepfer
Journal:  J Neurosci       Date:  2004-03-17       Impact factor: 6.167

9.  Distinct changes in synaptic protein composition at neuromuscular junctions of extraocular muscles versus limb muscles of ALS donors.

Authors:  Jing-Xia Liu; Thomas Brännström; Peter M Andersen; Fatima Pedrosa-Domellöf
Journal:  PLoS One       Date:  2013-02-26       Impact factor: 3.240

10.  Altered microRNA expression profile in Amyotrophic Lateral Sclerosis: a role in the regulation of NFL mRNA levels.

Authors:  Danae Campos-Melo; Cristian A Droppelmann; Zhongping He; Kathryn Volkening; Michael J Strong
Journal:  Mol Brain       Date:  2013-05-24       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.